Literature DB >> 9308974

Juvenile Huntington disease in the Netherlands.

S Siesling1, M Vegter-van der Vlis, R A Roos.   

Abstract

Juvenile Huntington disease (JHD) patients are distinguished from adult patients by an age at onset of less than 20 years. Investigating patients in our own database, we examined the proposition derived from studies in world literature that JHD should not be viewed as a separate clinical entity but rather as a manifestation of the rigid variant of the disease. Of 53 patients with JHD recorded in the Leiden Roster for Huntington Disease, relationships between sex, age at onset, duration of illness, maternal or paternal inheritance, motor symptom, first clinical features, and characteristics during the disease course, were obtained from the patients' files, and investigated. Although chorea is present in JHD, patients more often developed rigidity. Paternal inheritance, early dementia, epilepsy/myoclonus, and tremor during the disease course are confined for the most part to the rigid cases. A shorter duration of illness was evident in male patients with rigid JHD who inherited the disease from their father and developed their first disease feature at a younger age. The recognition of JHD as a distinct clinical entity does not appear to be warranted. Therefore, we propose, in accordance with other investigators, that rigid JHD be considered a clinical variant with special features.

Entities:  

Mesh:

Year:  1997        PMID: 9308974     DOI: 10.1016/s0887-8994(97)00069-6

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  10 in total

1.  Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study.

Authors:  Kevin M Biglan; Christopher A Ross; Douglas R Langbehn; Elizabeth H Aylward; Julie C Stout; Sarah Queller; Noelle E Carlozzi; Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Mov Disord       Date:  2009-09-15       Impact factor: 10.338

2.  Managing juvenile Huntington's disease.

Authors:  Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri
Journal:  Neurodegener Dis Manag       Date:  2013-06-01

Review 3.  Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings.

Authors:  Sandra M Holley; Talia Kamdjou; Jack C Reidling; Brian Fury; Dane Coleal-Bergum; Gerhard Bauer; Leslie M Thompson; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-03-06       Impact factor: 5.243

4.  Huntington's Disease.

Authors:  Donald S Higgins
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

5.  Huntington's Disease and Striatal Signaling.

Authors:  Emmanuel Roze; Emma Cahill; Elodie Martin; Cecilia Bonnet; Peter Vanhoutte; Sandrine Betuing; Jocelyne Caboche
Journal:  Front Neuroanat       Date:  2011-08-23       Impact factor: 3.856

Review 6.  Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.

Authors:  Hannah S Bakels; Raymund A C Roos; Willeke M C van Roon-Mom; Susanne T de Bot
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

7.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

Review 8.  Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.

Authors:  Adanna G Alexander; Vanessa Marfil; Chris Li
Journal:  Front Genet       Date:  2014-09-05       Impact factor: 4.599

9.  Brain structure in juvenile-onset Huntington disease.

Authors:  Alexander Tereshchenko; Vincent Magnotta; Eric Epping; Katherine Mathews; Patricia Espe-Pfeifer; Erin Martin; Jeffrey Dawson; Wenzhen Duan; Peg Nopoulos
Journal:  Neurology       Date:  2019-04-10       Impact factor: 11.800

Review 10.  Huntington disease: a single-gene degenerative disorder of the striatum.

Authors:  Peggy C Nopoulos
Journal:  Dialogues Clin Neurosci       Date:  2016-03       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.